Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacyJohn M L Ebos, Christina R Lee, James G Christensen, et al.
Plos Computational Biology|August 29, 2014
Classical mathematical models for description and prediction of experimental tumor growthSébastien Benzekry, Clare Lamont, Afshin Beheshti, et al.
Current Drug Targets|December 10, 2015
The Challenges of Modeling Drug Resistance to Antiangiogenic TherapyMichalis Mastri, Spencer Rosario, Amanda Tracz, et al.
World Journal of Oncology|March 13, 2026
Expression of Bruton's Tyrosine Kinase Reflects Immune Cells Infiltration and Cell Proliferation in Breast CancerTamrah AlRammah, Rongrong Wu, Kohei Chida, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatisRobert S Kerbel, Eric Guerin, Giulio Francia, et al.
Molecular Cancer Therapeutics|April 27, 2018
Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint InhibitorsMichalis Mastri, Christina R Lee, Amanda Tracz, et al.
Molecular Cancer Research : MCR|December 24, 2002
Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemiaJohn M L Ebos, Jennifer Tran, Zubin Master, et al.
Bio-Protocol|August 28, 2025
Isolation and Ex Vivo Testing of CD8+ T-Cell Division and Activation Using Mouse SplenocytesMelissa Dolan, Yuhao Shi, Amber McKenery, et al.
Pageof 4